the vaccine – Page 47 – Communicable Diseases Research

Comparing SARS-CoV-2 Antibody Responses after Various COVID-19 Vaccinations in Healthcare Workers

Communication

Published on 2022-01-262022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] Abbott Abbott SARS-CoV-2 IgG II Quant assay acute respiratory syndrome adverse event adverse events antibody Antibody assays Antibody Response AstraZeneca-Oxford blood specimen BNT162b2 ChAdOx1 collected coronavirus Coronavirus disease 2019 correlated COVID-19 COVID-19 vaccination COVID-19 vaccine Elecsy Elecsys Anti-SARS-CoV-2 S assay group healthcare healthcare worker Inc. investigated janssen JNJ-78436735 Moderna mRNA-1273 neutralizing antibody Pfizer-BioNTech Pfizer/BioNTech positive rate questionnaire reached response Roche Diagnostics SARS-CoV-2 SARS-CoV-2 IgG significantly significantly increased South Korea specimen subject the vaccine vaccination Vaccine was tested was used worker
[DOI] 10.3390/vaccines10020193 PMC 바로가기 [Article Type] Communication

Hesitancy towards a COVID-19 vaccine among midwives in Turkey during the COVID-19 pandemic: A cross-sectional web-based survey

Research Paper

Published on 2022-01-262022-11-01
Journal: European Journal of Midwifery [Category] COVID-19,

N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition

Research Article

Published on 2022-01-252022-10-29
Journal: mBio [Category] COVID-19, COVID19(2023년), MERS, SARS,

[키워드] ACE2 acute respiratory syndrome Brain CAP caused comparable Complete contribute coronavirus coronavirus disease CoV COVID-19 disease effective vaccine exhibited expression guanine IFN-I immune response immunological in vitro Infection Innate interferons ISG15 liver MDA5 MHV mice morbidity and mortality mouse hepatitis virus mutant mutant virus Mutation myeloid cell N7-methylation nonstructural protein 14 nonstructural protein 14 (nsp14) nsp14 pandemic Pathogenesis phenotype Prevent Preventing previous study Recognition reduced replicated required restored RNA RNA cap structure RNA methylation SARS-CoV-2 SARS-COV-2 infection Signaling significantly subsequent the vaccine therapy transgenic mice type I interferon understanding upregulated viral replication Viral RNA virulence wild-type
[DOI] 10.1128/mbio.03662-21 PMC 바로가기 [Article Type] Research Article

Cellular Immune Response after Vaccination in Patients with Cancer—Review on Past and Present Experiences

Review

Published on 2022-01-252022-10-28
Journal: Vaccines [Category] COVID-19,

Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects? A Retrospective Cross-Sectional Study

Article

Published on 2022-01-252022-10-28
Journal: Vaccines [Category] COVID-19,

On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine

새로운 B.1.1.529 변종의 부상: COVID-19 백신에 대한 접근의 5가지 차원

Article

Published on 2022-01-242022-09-11
Journal: Vaccine [Category] SARS, 변종,

Should We Delay the Second COVID-19 Vaccine Dose in Order to Optimize Rollout? A Mathematical Perspective

롤아웃을 최적화하기 위해 두 번째 COVID-19 백신 접종을 연기해야 합니까? 수학적 관점

Public Health Archive

Published on 2022-01-242022-09-10
Journal: International Journal of Public Health [Category] MERS, SARS, 변종,

Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection

합성 SARS-CoV-2 S 당단백질 바이러스 유사 입자로 면역화하여 원숭이를 감염으로부터 보호

Article

Published on 2022-01-242022-09-11
Journal: Cell Reports Medicine [Category] COVID19(2023년), MERS, SARS, 변종, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Alpha anti-receptor-binding domain anti-S antibodies Antibody Response Antibody titer Antibody titers approach B cells Beta boost caused CD4 classical clinical testing coated Complete coronavirus COVID-19 cynomolgus macaque cynomolgus macaques formaldehyde formaldehyde cross-linking Gamma Health Health crisis IgA titers IgG Immunity immunization Immunoglobulin Immunoglobulin G induce Infection macaque macaques Nanoparticles nasopharyngeal Neutralizing activity pandemic predominant PROTECT protection Receptor-binding domain receptor-binding domains respiratory S glycoprotein Safe SARS-CoV-2 SARS-CoV-2 S glycoprotein SARS-CoV-2 spike severe acute respiratory syndrome Coronavirus sterilizing immunity T cell T cell responses T helper the vaccine trimer vaccine candidate vaccine strain variant Vesicle Virus-like particle virus-like particles
[DOI] 10.1016/j.xcrm.2022.100528 PMC 바로가기 [Article Type] Article

Acute Myocardial Infarction After Coronavirus Vaccine: A Rare Adverse Effect

Cardiology

Published on 2022-01-242022-10-31
Journal: Cureus [Category] COVID-19,

RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine

Research

Published on 2022-01-242022-10-28
Journal: BMC Infectious Diseases [Category] COVID-19, SARS,